Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment for children and young people news

Show

From To
Starting treatment quickly after diagnosis is not harmful for adolescents, Zimbabwe study finds

A lack of lengthy preparation before starting HIV treatment does not result in an increased risk of death or loss to follow-up in adolescents, a

Published
25 January 2017
By
Keith Alcorn
New strategy aims to end AIDS in children by 2020

A new strategy to end paediatric AIDS launched at the 21st International AIDS Conference (AIDS 2016) in Durban, South Africa, on Tuesday calls for antiretroviral treatment services

Published
19 July 2016
By
Keith Alcorn
HIV treatment programmes need to prepare for the 'youth bulge', South African experience shows

Treatment programmes in sub-Saharan Africa must prepare for a growing population of adolescents over the next few years as children born with HIV grow up and begin

Published
19 July 2016
By
Carole Leach-Lemens
Adolescents are dying of AIDS at an alarming rate, UN agency warns

An average of 29 adolescents between the ages of 15 and 19 are infected with HIV every hour, according to the United Nations Children's Fund, which is calling for a redoubling of prevention and treatment efforts.

Published
19 July 2016
From
UN News Centre
“Towards Ending the Neglect?” DNDi Releases Update on its Paediatric HIV Programme

The Drugs for Neglected Diseases initiative (DNDi) has released an update on its efforts to develop optimal child-adapted antiretroviral formulations. This document details some recent progress towards its final goal of developing “4-in-1” fixed-dose combinations using the World Health Organization (WHO) recommended treat­ment regimen for infants and young chil­dren.

Published
17 July 2016
From
DNDi
ART use averting huge numbers of opportunistic infections among children living with HIV in lower-income countries

There has been a decrease in cases of many opportunistic infections (OIs) among children living with HIV in low- and middle-income countries thanks to antiretroviral therapy (ART),

Published
27 June 2016
By
Michael Carter
UNAIDS and PEPFAR announce dramatic reductions in new HIV infections among children in the 21 countries most affected by HIV in Africa

Concerted global efforts have led to a 60% drop in new infections among children, which has averted 1.2 million new HIV infections among children in 21 priority countries since 2009.

Published
08 June 2016
From
UNAIDS
HIV in children is a symptom of the failures of the AIDS response

Leaders from West and Central Africa urged to mobilize national and international political commitment for an ambitious catch up plan to intensify the HIV response in the region.

Published
10 May 2016
From
MSF
Dolutegravir safe and highly effective in older children

Dolutegravir (DTG) plus optimised background regimen (OBR) is safe, well tolerated and provides virologic efficacy in HIV-infected children from six to 12 years of age at 48

Published
25 February 2016
By
Carole Leach-Lemens
Efavirenz-based treatment is safe and effective for young children with HIV exposed to nevirapine for PMTCT

Efavirenz-based treatment is a safe and effective treatment option for children living with HIV previously exposed to nevirapine for the prevention of mother-to-child transmission (PMTCT)

Published
19 January 2016
By
Michael Carter

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.